Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fixed-Dose Combination of Perindopril/Amlodipine (Amlessa®) and Fixed-Dose Combination of Perindopril/Indapamide /Amlodipine (Co-Amlessa®) - Contribution to Management in Newly Diagnosed and Uncontrolled Hypertensive Patients

NCT03738761 is registered in ClinicalTrials.gov with KRKA as lead sponsor.

NCT NCT03738761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03738761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fixed-Dose Combination of Perindopril/Amlodipine (Amlessa®) and Fixed-Dose Combination of Perindopril/Indapamide /Amlodipine (Co-Amlessa®) - Contribution to Management in Newly Diagnosed and Uncontrolled Hypertensive Patients
Lead sponsor
KRKA
Phase
Phase 4
Overall status
Completed
Start date
February 13, 2018
Completion date
September 27, 2019
Enrollment
471 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension